Bacillus Calmette-Guérin (BCG) vaccines are given to more than 100 million children every year, but there is considerable debate regarding the effectiveness of BCG vaccination in preventing ...

In a recent study posted to the bioRxiv* preprint server, researchers assessed the impact of Bacillus Calmette-Guérin (BCG) vaccination on the protection provided by severe acute respiratory syndrome ...

The immune boosting benefits of a tuberculosis vaccine can be seen in infants more than one year after vaccination, according to a new study. The research, led by the Murdoch Children's Research ...

Infants who received BCG [bacille Calmette-Guérin] vaccination at birth had protection against tuberculosis into early childhood, but that protection largely disappeared in only a few years, according ...

During the frightening early weeks of the COVID-19 pandemic in March of 2020, Kiehl Sundt, of Sequim, Washington, became one of the first people on Earth to receive an experimental dose of Moderna’s ...

The bacillus Calmette-Guérin (BCG) vaccine nearly halved the risk of progression among patients with non–muscle invasive bladder cancer (NMIBC) compared with transurethral resection of the bladder ...

Researchers headed by a team at Pitt University, in collaboration with scientists at Cornell University, have developed a self-destructing, intravenous (i.v.) Bacillus Calmette-Guérin (BCG) vaccine ...

There’s a vaccine available for tuberculosis. However, it’s not commonly given in the United States. One reason why is that tuberculosis is no longer as common in the United States as it once was.

The Johns Hopkins Center for Immunization Research is looking for volunteers to participate in an outpatient BCG vaccine study. If you are a healthy adult between the ages of 18 and 65, you may be ...